The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.
The latest issue of Leading Discoveries magazine is now available online, highlighting research-driven advances in cancer science and medicine. Read the magazine: brnw.ch/21x3kmc
The @US_FDA approved the targeted therapy capivasertib with the hormone therapy abiraterone and the steroid prednisone for adults with PTEN-deficient metastatic androgen pathway modulation-naïve or -sensitive (mAPMN/S) prostate cancer: brnw.ch/21x3jku
Protect your skin this weekend; remember to include sunscreen in your supplies as you plan your fun in the sun. Exposure to sunlight is the top risk factor for #skincancer. brnw.ch/21x3jfX
Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more:
brnw.ch/21x3jfo#SABCS26
The @US_FDA approved the targeted therapy belzutifan with the immunotherapy pembrolizumab, administered intravenously or subcutaneously, for certain adults with clear cell renal cell carcinoma at intermediate-high or high-risk following surgery: brnw.ch/21x3j4B
Degraders in the Era of Precision Oncology:
Richard Caldwell, Chinatsu Sakata, Ryan Potts, and David Puleo will address this topic in a plenary at the AACR Conference on Drug Discovery and Development (July 21-24; Boston).
brnw.ch/21x3j1k#AACRdrugdev26@pottslab
Submit an abstract by July 9 for the AACR Special Conference on Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more:
brnw.ch/21x3iQl#AACRpediatric26
Everyone's experience with cancer is deeply personal. Whether you're a patient, survivor, caregiver, or loved one, your story can offer hope, inspiration, and strength to others facing similar challenges. Share your story: brnw.ch/21x3is4#NationalCancerSurvivorMonth
Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression. Learn about the importance of early detection: brnw.ch/21x3hsF
Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes.
brnw.ch/21x3hhN#AACRpan26@EileenMOReilly
Submit an abstract by July 8 for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (November 18-20; Barcelona, Spain), chaired by Elena Garralda, Ryan Corcoran, and Tim Greten. Learn more:
brnw.ch/21x3h4S@EORTC@theNCI
Register by June 12 to get the lowest rates for the AACR Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver), chaired by Andy Futreal, Taran Gujral, Brooke E. Howitt, and Patrick Tan. Learn more:
brnw.ch/21x3gU4#AACRrarecancers26
Learn more about how researchers like @tae_hwang are building agentic AI to augment clinicians and assist in planning cancer treatment on the #AACRBlog: brnw.ch/21x3gv3
Nearly 159,000 people in the United States will be diagnosed with colorectal cancer this year. Read about the prevention, screening, and treatment options for #ColorectalCancer: brnw.ch/21x3fvV
New AACR Conference:
Save the date for the AACR Lung Cancer Conference (January 14-17, 2027; San Diego), held in association with the AACR Lung Cancer Task Force and chaired by Charles Swanton. Learn more:
brnw.ch/21x3fnm#AACRlung27@CharlesSwanton
The Fellows of the AACR Academy Cancer Research Impact Grants are one-year, $75,000 awards that support early-career investigators nearing completion of postdoctoral or clinical research training. Apply by June 30. Learn more:
brnw.ch/21x3fhD#AACRGrants
On a recent Believe in Progress podcast, Michael Hugo shared his glioblastoma journey—from innovative treatments to cancer research advocacy. During #NationalCancerSurvivorMonth, hear his story and others that inspire hope and progress: brnw.ch/21x3fbW
The AACR-Exelixis Renal Cell Carcinoma Research Fellowship provides $130,000 over two years to support postdoctoral or clinical research fellows. Research must have direct applicability and relevance to renal cell carcinoma. Apply by June 11:
brnw.ch/21x3f0M
Register by June 16 for the Ninth JCA-AACR Special Joint Conference on Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers (June 28-30; Kyoto, Japan), chaired by Toshikazu Ushijima and Lillian L. Siu. Learn more:
brnw.ch/21x3euw